Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Basiliximab 20 Mg Pow (CDM 7330122) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 25, 2026 , from http://ppman.hank.ai/transparency/procedure/7330122/by-state?code_type=CDM
“Basiliximab 20 Mg Pow (CDM 7330122) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/7330122/by-state?code_type=CDM. Accessed
October 25, 2026 .
“Basiliximab 20 Mg Pow (CDM 7330122) by State,” HANK Price Transparency ,
accessed October 25, 2026 ,
http://ppman.hank.ai/transparency/procedure/7330122/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
7330122 — Basiliximab 20 Mg Pow
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$10,067
National median
$6,596 – $10,450
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 7330122 (CDM), with interquartile range
State Median p25 p75
CO $10,067 $6,596 $10,450